Arvee Laboratories (India) (NSE:ARVEE) Enterprise Value: ₹1,716.7 Mil (As of Jul. 16, 2026) ***

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ARVEE Arvee Laboratories (India) Ltd NSE:ARVEE
75 GF Score
Price ₹161.10
GF Value ₹123.69
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Arvee Laboratories (India) Enterprise Value?

Arvee Laboratories (India) NSE:ARVEE +1.32% 75 Enterprise Value is ₹1,716.7 Mil as of Jul. 16, 2026. GuruFocus rates NSE:ARVEE with a GF Score™ of 75/100 and a GF Value™ of ₹123.69 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Arvee Laboratories (India)'s Enterprise Value is ₹1,716.7 Mil. Arvee Laboratories (India)'s EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was ₹18.0 Mil. Therefore, Arvee Laboratories (India)'s EV-to-EBIT ratio for today is 95.61.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Arvee Laboratories (India)'s Enterprise Value is ₹1,716.7 Mil. Arvee Laboratories (India)'s EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was ₹29.6 Mil. Therefore, Arvee Laboratories (India)'s EV-to-EBITDA ratio for today is 57.93.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Arvee Laboratories (India)'s Enterprise Value is ₹1,716.7 Mil. Arvee Laboratories (India)'s Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was ₹271.1 Mil. Therefore, Arvee Laboratories (India)'s EV-to-Revenue ratio for today is 6.33.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Arvee Laboratories (India)'s Enterprise Value is ₹1,716.7 Mil. Arvee Laboratories (India)'s Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was ₹0.0 Mil. Therefore, Arvee Laboratories (India)'s EV-to-OCF ratio for today is .

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Arvee Laboratories (India)'s Enterprise Value is ₹1,716.7 Mil. Arvee Laboratories (India)'s Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was ₹0.0 Mil. Therefore, Arvee Laboratories (India)'s EV-to-FCF ratio for today is .

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Arvee Laboratories (India)  (NSE:ARVEE) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Arvee Laboratories (India)'s EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1716.743/17.955
=95.61

Arvee Laboratories (India)'s current Enterprise Value is ₹1,716.7 Mil.
Arvee Laboratories (India)'s EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹18.0 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Arvee Laboratories (India)'s EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=1716.743/29.637
=57.93

Arvee Laboratories (India)'s current Enterprise Value is ₹1,716.7 Mil.
Arvee Laboratories (India)'s EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹29.6 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Arvee Laboratories (India)'s EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1716.743/271.112
=6.33

Arvee Laboratories (India)'s current Enterprise Value is ₹1,716.7 Mil.
Arvee Laboratories (India)'s Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹271.1 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Arvee Laboratories (India)'s EV-to-OCF for today is:


Arvee Laboratories (India)'s current Enterprise Value is ₹1,716.7 Mil.
Arvee Laboratories (India)'s Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Arvee Laboratories (India)'s EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1716.743/0
=

Arvee Laboratories (India)'s current Enterprise Value is ₹1,716.7 Mil.
Arvee Laboratories (India)'s Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arvee Laboratories (India) Enterprise Value Related Terms


Arvee Laboratories (India) Enterprise Value Historical Data

* Premium members only.

The historical data trend for Arvee Laboratories (India)'s Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arvee Laboratories (India) Enterprise Value Chart

Arvee Laboratories (India) Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 612.91 1,253.20 970.79 1,571.61 1,526.00

Arvee Laboratories (India) Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,914.95 1,526.00 1,953.63 1,505.41 2,347.70

NSE:ARVEE vs LIN, SHW, ECL: Enterprise Value Comparison

For the Specialty Chemicals subindustry, Arvee Laboratories (India)'s Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arvee Laboratories (India) Enterprise Value vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Arvee Laboratories (India)'s Enterprise Value distribution charts can be found below:

* The bar in red indicates where Arvee Laboratories (India)'s Enterprise Value falls into.


NSE:ARVEE
75GF Score
Arvee Laboratories (India) Ltd NSE:ARVEE
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arvee Laboratories (India) Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Arvee Laboratories (India)'s Enterprise Value for the fiscal year that ended in Mar. 2025 is calculated as

Arvee Laboratories (India)'s Enterprise Value for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of ₹1,716.7 Mil mean?
Arvee Laboratories (India) (NSE:ARVEE) has a Enterprise Value of ₹1,716.7 Mil as of Jul. 16, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Arvee Laboratories (India) and its competitors.
Is Arvee Laboratories (India)'s Enterprise Value too high?
Arvee Laboratories (India)'s current Enterprise Value is ₹1,716.7 Mil. Overall, Arvee Laboratories (India) has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvee Laboratories (India)'s Enterprise Value compare to LIN and SHW?
Arvee Laboratories (India)'s Enterprise Value of ₹1,716.7 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Chemicals company?
A good Enterprise Value depends on the Chemicals industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Arvee Laboratories (India) and its competitors. Arvee Laboratories (India)'s current Enterprise Value is ₹1,716.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvee Laboratories (India) stock overvalued right now?
Based on GuruFocus' analysis, Arvee Laboratories (India) (NSE:ARVEE) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹123.69, compared to a current price of ₹161.10 — trading 30.2% above its estimated fair value. The current Enterprise Value is ₹1,716.7 Mil. Arvee Laboratories (India)'s overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Arvee Laboratories (India) (NSE:ARVEE), the current Enterprise Value is ₹1,716.7 Mil as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arvee Laboratories (India) (NSE:ARVEE) Overvalued in 2026?

Based on GuruFocus' analysis, Arvee Laboratories (India) stock appears to be overvalued. The current stock price of ₹161.10 is trading 30.2% above its estimated GF Value™ of ₹123.69. GuruFocus considers Arvee Laboratories (India) to be Modestly Overvalued.

Key valuation signals for NSE:ARVEE:

  • Enterprise Value: ₹1,716.7 Mil
  • GF Value™: ₹123.69 vs. price of ₹161.10 (30.2% above fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the NSE:ARVEE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arvee Laboratories (India) Business Description

Address Iskcon Bopal Road, 403, Entice Building, Opposite Jayantilal Park BRTS Bus Stop, Ambli, Ahmedabad, GJ, IND, 380058
Arvee Laboratories (India) Ltd is a specialty chemical company. Its products include Polymer Modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, and others, Contrast Media Intermediates such as Dimethyl 5-Aminoisophthalate, 3,5-Diamino Benzoic Acid, 5-Nitroisophthalic acid and others; and Drug Intermediates like 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde and others. Geographically, the company principally operates in India.
75GF Score

Get the complete analysis for NSE:ARVEE

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹161.10
Price
₹123.69
GF Value